Two Sigma Securities, LLC Cerus Corp Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $24,912 - $50,986	16,608 New	16,608 $26,000
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $26,322 - $37,844	9,933 Added 85.43%	21,560 $64,000
Q4 2022 Feb 14, 2023	BUY	$3.38 - $4.22 $39,299 - $49,065	11,627 New	11,627 $42,000
Q1 2019 May 15, 2019	SELL	$5.16 - $6.85 $55,949 - $74,274	-10,843 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $53,022 - $77,635	10,843 New	10,843 $55,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $68,549 - $95,758	-13,208 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.56 - $5.74 $206 - $332	-58 Reduced 0.44%	13,208 $72,000
Q4 2017 Feb 14, 2018	BUY	$2.76 - $3.95 $36,614 - $52,400	13,266	13,266 $45,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.